FOX BIZ NEWS: AstraZeneca to buy Alexion for $39 billion to expand in immunology
AstraZeneca to buy Alexion for $39 billion to expand in immunology
![](https://static.foxbusiness.com/foxbusiness.com/content/uploads/2020/09/AP20245570629611.jpg)
Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.
Comments
Post a Comment